With your own knowledge and the help of the following document:

Document 1 (Title: Clinical Management of Acute Salicylism): Salicylate poisoning presents distinctive toxicological patterns requiring age-specific management approaches and targeted interventions addressing multiple pathophysiological derangements. Pediatric considerations assume particular importance, with children demonstrating increased susceptibility to toxic effects at lower relative doses compared to adults due to immature metabolic pathways, limited glycogen stores, and reduced buffering capacity. These age-related differences necessitate more aggressive intervention thresholds and closer monitoring parameters when managing suspected pediatric exposures. Gastrointestinal decontamination approaches include considerations regarding activated charcoal administration, which should be implemented following rather than during gastric lavage procedures when both interventions are indicated, as concurrent administration reduces lavage efficacy through material binding while potentially increasing aspiration risk. Acid-base management represents a cornerstone of treatment, with intravenous sodium bicarbonate serving dual therapeutic purposes: correcting the characteristic metabolic acidosis while simultaneously alkalinizing urine to enhance salicylate elimination through ion trapping mechanisms. This alkalinization approach significantly increases renal clearance, with studies demonstrating 5-10 fold improvements in elimination rates when urinary pH exceeds 7.5 compared to acidic urine conditions. Respiratory manifestations follow predictable patterns, with hyperventilation representing an early compensatory response to metabolic acidosis rather than a late complication. This respiratory alkalosis can partially mask the severity of underlying metabolic derangements, necessitating careful interpretation of blood gas parameters rather than relying solely on clinical respiratory assessment. Comprehensive management protocols incorporating these principles have significantly reduced mortality rates compared to historical outcomes, particularly when implemented promptly following confirmed or suspected significant exposures.
Document 2 (Title: Management Approaches for Acetaminophen Toxicity): Paracetamol (acetaminophen) overdose represents a common and potentially life-threatening poisoning requiring evidence-based management approaches guided by pharmacokinetic and metabolic considerations. Initial interventions focus on reducing absorption, with substantial evidence supporting early activated charcoal administration when patients present within 1-2 hours post-ingestion. Multiple controlled studies document 50-70% reductions in paracetamol bioavailability following timely charcoal administration, significantly altering toxicity risk assessments. Gastrointestinal decontamination approaches include gastric lavage, which demonstrates particular utility when performed within 60 minutes of ingestion for substantial overdoses, representing an important intervention alongside activated charcoal in early presentations. The hepatotoxicity mechanism involves a complex metabolic pathway wherein a small percentage of paracetamol undergoes cytochrome P450-mediated (primarily CYP2E1) biotransformation generating the reactive intermediate N-acetyl-p-benzoquinone imine (NAPQI), which depletes glutathione and subsequently binds cellular proteins causing hepatocellular damage. Antidotal therapy with N-acetylcysteine works through multiple mechanisms including glutathione precursor provision and alternative metabolic pathway enhancement, with administration protocols varying between oral and intravenous routes. Importantly, concurrent administration of oral N-acetylcysteine with activated charcoal results in significant adsorption and reduced antidote bioavailability, necessitating dosage adjustments or separated administration when both interventions are indicated. Clinical progression typically follows a characteristic pattern, with hepatotoxicity markers including transaminase elevations developing 24-48 hours post-ingestion rather than presenting as early manifestations, contrasting with other toxic presentations where renal dysfunction may present earlier. These pharmacological and clinical characteristics inform evidence-based management approaches balancing gastrointestinal decontamination, antidotal therapy, and supportive care for optimal outcomes.
Document 3 (Title: Ethylene glycol poisoning): Signs and symptoms Signs of ethylene glycol poisoning depend upon the time after ingestion. Symptoms usually follow a three step progression, although poisoned individuals will not always develop each stage. Stage 1 (30 minutes to 12 hours) consists of neurological and gastrointestinal symptoms and looks similar to alcohol poisoning. Poisoned individuals may appear to be intoxicated, dizzy, lacking coordination of muscle movements, drooling, depressed, and have slurred speech, seizures, abnormal eye movements, headaches, and confusion. Irritation to the stomach may cause nausea and vomiting. Also seen are excessive thirst and urination. Over time, the body metabolizes ethylene glycol into other toxins. Stage 2 (12 to 36 hours) where signs of “alcohol” poisoning appear to resolve, underlying severe internal damage is still occurring. An elevated heart rate, hyperventilation or increased breathing effort, and dehydration may start to develop, along with high blood pressure and metabolic acidosis. These symptoms are a result of accumulation of organic acids formed by the metabolism of ethylene glycol. Additionally low calcium concentrations in the blood, overactive muscle reflexes, muscle spasms, QT interval prolongation, and congestive heart failure may occur. If untreated, death most commonly occurs during this period. Stage 3 (24 to 72 hours) kidney failure is the result of ethylene glycol poisoning. In cats, this stage occurs 12–24 hours after consuming antifreeze; in dogs, at 36–72 hours after consuming antifreeze. During this stage, severe kidney failure is developing secondary to calcium oxalate crystals forming in the kidneys. Severe lethargy, coma, depression, vomiting, seizures, drooling, and inappetence may be seen. Other symptoms include acute tubular necrosis, red blood cells in the urine, excess proteins in the urine, lower back pain, decreased or absent production of urine, elevated blood concentration of potassium, and acute kidney failure. If kidney failure occurs it is typically reversible, although weeks or months of supportive care including hemodialysis may be required before kidney function returns.

Answer the following list question.
Question: Select the correct statement(s) regarding salicylate poisoning:
Options:
1. Young children are more sensitive than adults to salicylate overdose
2. The use of activated charcoal is not recommended during gastric lavage
3. Intravenous administration of sodium bicarbonate allows correction of metabolic acidosis
4. Intravenous administration of sodium bicarbonate increases urinary elimination of salicylates
5. Hyperventilation is common at the beginning of the intoxication

Respond strictly in valid JSON format as shown below:
{"answer": ["1", "3"]} ← if options 1 and 3 are correct
Only output the JSON object. Do not include explanations, labels, markdown, or any other text.